Annals of Surgical Oncology · 2013 · 36 citations · 22 references
MedicineOncologyPharmacologyMetastasisSurvival AnalysisTumor ProgressionCancer ProgressionCancer Survival AnalysisKidney CancerMalignant NeoplasmsMetastatic Cancer ManagementRenal Cell CarcinomaCancer Prognostic ModelingMetastatic Kidney CancerMetastatic Renal Cell Carcinoma TherapyPrognostic Prediction ModelsRenal Cell Carcinoma Systemic Therapy
22
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 5.8K citations · Full text
Medicine, Oncology, Pharmacology +14
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text
Medicine, Nephrology, Oncology +11